Home Visit Intervention in Pediatric Palliative Care
Palliative Intervention to Improve Quality of Life in Children With Cancer: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
A randomized controlled trial to compare the quality of life between participants who were given palliative care (a 3-month home visit) and those who were not (intervention vs control group) was conducted. Participants consisted of children with cancer aged 2-18 years old. A two-way communication between a trained health worker and participants with or without their parents were conducted as the intervention (report by proxy or self-report). Interventions were given in 6 sessions (1 session every 2 weeks) focusing on problems solving education, symptoms management, self-care, communication, decision making, and long-term care plan assistance. In the first and twelfth week of the intervention, all participants were assessed with the Pediatric Quality of Life Inventory (PedsQLTM) questionnaire cancer module 3.0. Symptomps intensityof anorexia, sleep diturbance, and pain will be asessed in each visit. Participants were followed, Emergency Room (ER) admissions were recorded during follow up period. During the follow up period, ER admissions were recorded further.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 22, 2019
CompletedFirst Posted
Study publicly available on registry
August 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedDecember 9, 2019
December 1, 2019
6 months
August 22, 2019
December 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life cancer child
Measured using PedsQLTM cancer module 3.0 that consisted of eight dimension. Each dimension consisted of several items to be answered. Item scaling was answered in 5-point Likert scale from 0 (Never) to 4 (Almost always). Scores are transformed to a 0 to 100 scale. Items are reversed scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, 4=0. If more than 50% of the items in the scale are missing, the scale scores should not be computed. Mean score = Sum of the items over the number of items answered. Total score is acquired by summing of all the items over the number of items answered on all the Scales.Higher scores indicate lower problems.
at the end of 3 months follow up
Secondary Outcomes (2)
Emergency room visits
during 3 months follow up
Symptomps intensity
during 3 months follow up
Study Arms (2)
Control
NO INTERVENTIONNo palliative home visit intervention
Intervention
EXPERIMENTALPalliative home visit intervention
Interventions
a 3-month home visit, providing two-way communication between a trained health worker and patients with or without their parents were conducted as the intervention (report by proxy or self-report). Interventions were given in 6 sessions (1 session every 2 weeks) focusing on problems solving education, symptoms management, self-care, communication, decision making, and long-term care plan assistance.
Eligibility Criteria
You may qualify if:
- Child age 2-18 years old with malignancies who undergo treatments at the Department of Child Health of Cipto Mangunkusumo Hospital, during the study period.
- All participants who meet the criteria to get palliative care, participants with a total score ≥ 4 based on palliative screening form.
- Participants and or parents agree to be enrolled in study
You may not qualify if:
- Patients who live outside Jakarta and therefore unreachable to get palliative intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cipto Mangunkusumo Hospital
Jakarta, 10430, Indonesia
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Murti Andriastuti, Doctor
Indonesia University, Cipto Mangunkusumo Hospital Jakarta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 22, 2019
First Posted
August 26, 2019
Study Start
January 1, 2019
Primary Completion
July 1, 2019
Study Completion
September 30, 2019
Last Updated
December 9, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share